These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 25572959)
1. Anti-platelet activity of water dispersible curcuminoids in rat platelets. Maheswaraiah A; Rao LJ; Naidu KA Phytother Res; 2015 Mar; 29(3):450-8. PubMed ID: 25572959 [TBL] [Abstract][Full Text] [Related]
2. Synthetic curcuminoids modulate the arachidonic acid metabolism of human platelet 12-lipoxygenase and reduce sprout formation of human endothelial cells. Jankun J; Aleem AM; Malgorzewicz S; Szkudlarek M; Zavodszky MI; Dewitt DL; Feig M; Selman SH; Skrzypczak-Jankun E Mol Cancer Ther; 2006 May; 5(5):1371-82. PubMed ID: 16731771 [TBL] [Abstract][Full Text] [Related]
3. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Srivastava KC; Bordia A; Verma SK Prostaglandins Leukot Essent Fatty Acids; 1995 Apr; 52(4):223-7. PubMed ID: 7784468 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Shah BH; Nawaz Z; Pertani SA; Roomi A; Mahmood H; Saeed SA; Gilani AH Biochem Pharmacol; 1999 Oct; 58(7):1167-72. PubMed ID: 10484074 [TBL] [Abstract][Full Text] [Related]
5. Antiplatelet and antithrombotic effects of cordycepin-enriched WIB-801CE from Cordyceps militaris ex vivo, in vivo, and in vitro. Kwon HW; Shin JH; Lim DH; Ok WJ; Nam GS; Kim MJ; Kwon HK; Noh JH; Lee JY; Kim HH; Kim JL; Park HJ BMC Complement Altern Med; 2016 Dec; 16(1):508. PubMed ID: 27927214 [TBL] [Abstract][Full Text] [Related]
6. Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acid. Aharony D; Smith JB; Silver MJ Biochim Biophys Acta; 1982 Oct; 718(2):193-200. PubMed ID: 6814496 [TBL] [Abstract][Full Text] [Related]
7. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation. Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038 [TBL] [Abstract][Full Text] [Related]
8. Evidence for a role for phospholipase C, but not phospholipase A2, in platelet activation in response to low concentrations of collagen. Lockhart LK; Pampolina C; Nickolaychuk BR; McNicol A Thromb Haemost; 2001 May; 85(5):882-9. PubMed ID: 11372683 [TBL] [Abstract][Full Text] [Related]
9. Spice active principles as the inhibitors of human platelet aggregation and thromboxane biosynthesis. Raghavendra RH; Naidu KA Prostaglandins Leukot Essent Fatty Acids; 2009 Jul; 81(1):73-8. PubMed ID: 19501497 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of 12/15 lipoxygenase by curcumin and an extract from Curcuma longa L. Bezáková L; Košťálová D; Obložinský M; Hoffman P; Pekárová M; Kollárová R; Holková I; Mošovská S; Sturdík E Ceska Slov Farm; 2014 Feb; 63(1):26-31. PubMed ID: 24568335 [TBL] [Abstract][Full Text] [Related]
11. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF. Porta C; Maiolo A; Tua A; Grignani G Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928 [TBL] [Abstract][Full Text] [Related]
12. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase. Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303 [TBL] [Abstract][Full Text] [Related]
14. Anti-platelet activity of erythro-(7S,8R)-7-acetoxy-3,4,3',5'-tetramethoxy-8-O-4'-neolignan from Myristica fragrans. Kang JW; Min BS; Lee JH Phytother Res; 2013 Nov; 27(11):1694-9. PubMed ID: 23296979 [TBL] [Abstract][Full Text] [Related]
15. The antiplatelet activity of Geiji-Bokryung-Hwan, Korean traditional formulation, is mediated through inhibition of phospholipase C and inhibition of TxB(2) synthetase activity. Park WH; Kim KS; Kim KH; Kim DS; Kim CH Int Immunopharmacol; 2003 Jul; 3(7):971-8. PubMed ID: 12810354 [TBL] [Abstract][Full Text] [Related]
16. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets. Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910 [TBL] [Abstract][Full Text] [Related]
17. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets. Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903 [TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits GPVI-mediated platelet activation by interfering with the kinase activity of Syk and the subsequent activation of PLCgamma2. Mayanglambam A; Dangelmaier CA; Thomas D; Damodar Reddy C; Daniel JL; Kunapuli SP Platelets; 2010; 21(3):211-20. PubMed ID: 20158382 [TBL] [Abstract][Full Text] [Related]
19. [Activators, receptors and signal transduction pathways of blood platelets]. Shaturnyĭ VI; Shakhidzhanov SS; Sveshnikova AN; Panteleev MA Biomed Khim; 2014; 60(2):182-200. PubMed ID: 24837309 [TBL] [Abstract][Full Text] [Related]
20. Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated. Leo R; Praticò D; Iuliano L; Pulcinelli FM; Ghiselli A; Pignatelli P; Colavita AR; FitzGerald GA; Violi F Circulation; 1997 Feb; 95(4):885-91. PubMed ID: 9054746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]